Records containing: Vaginal Atrophy

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2019-05-20
  Effect of Hybrid Laser 10600+1540 nm on Vaginal Atrophy-genitourinary Syndrome of the Menopause
• CLINICAL_TRIALS study record update · 2019-03-15
  A Prospective Trial to Assess Breast Cancer Survivors and Vaginal Atrophy Treatment
• CLINICAL_TRIALS study record update · 2018-10-09
  EFFICACY AND SAFETY OF SPIL'S ESTRADIOL VAGINAL TABLET, 10 MCG ESTRADIOL IN SUBJECTS WITH VULVAR AND VAGINAL ATROPHY: A RANDOMIZED, OBSERVER BLIND, PARALLEL GROUPS, ACTIVE AND PLACEBO CONTROLLED, CLINICAL ENDPOINT BIOEQUIVALENCE STUDY
• CLINICAL_TRIALS study record update · 2018-07-02
  ClinicalTrials.gov study NCT02937805
• CLINICAL_TRIALS study record update · 2018-06-14
  Clinical Study of the CO2RE Laser Device Performance for Vaginal Atrophy Treatments
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2018-05-09
  A Randomized Controlled Trial for the Evaluation of Efficacy and Safety of Votiva for Vaginal Rejuvenation
• CLINICAL_TRIALS study record update · 2017-11-21
  Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects
• CLINICAL_TRIALS study record update · 2017-10-18
  DHEA Against Vaginal Atrophy - Safety Study of 12 Months
• CLINICAL_TRIALS study record update · 2017-06-12
  ClinicalTrials.gov study NCT01358760
• CLINICAL_TRIALS study record update · 2017-06-01
  ClinicalTrials.gov study NCT02013544
• CLINICAL_TRIALS study record update · 2017-04-28
  Topical DHEA Against Vaginal Atrophy (3-Month Placebo-Controlled Double-Blind Randomized Phase III Study)
• CLINICAL_TRIALS study record update · 2017-04-25
  DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
• CLINICAL_TRIALS study record update · 2017-04-07
  DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal Atrophy-Phase I Randomized,Placebo-Controlled, Double-Blind Study.
• CLINICAL_TRIALS study record update · 2015-10-08
  Ph IV , Longitudinal, Prospective, Open Label, Non-comparative, to Evaluate the Efficacy, Safety and Tolerability of a Non-hormonal Intravaginal Gel in Postmenopausal Women With Symptoms of Vaginal Dryness.
• CLINICAL_TRIALS study record update · 2015-05-28
  A Pharmacokinetic Study of Vaginally and Intravenously Administered Oxytocin in Postmenopausal Women With Vaginal Atrophy
• CLINICAL_TRIALS study record update · 2015-05-27
  The Effects of Local Vaginal Estrogen in Postmenopausal Women With Pelvic Organ Prolapse: A Randomized Control Trial
• CLINICAL_TRIALS study record update · 2013-07-15
  Vaginal Cytokines in Postmenopausal Women With Symptoms of Vulvovaginal Irritation
• CLINICAL_TRIALS study record update · 2012-02-08
  A Phase I/II Dose Escalation Clinical Trial to Assess Safety and Efficacy of VG101 to Treat the Symptoms of Vulvar and Vaginal Atrophy in Post-Menopausal Women
• CLINICAL_TRIALS study record update · 2011-09-13
  A Double-blind, Placebo Controlled Multi-centre Study to Evaluate the Effects of Topical Oxytocin on Vaginal Atrophy in Postmenopausal Women
• CLINICAL_TRIALS study record update · 2010-07-27
  Prospective Randomized Study on Efficacy and Safety of Clino-san® in the Management of Vaginal Dryness in Breast Cancer Patients
• CLINICAL_TRIALS study record update · 2007-12-28
  A Double-Blind, Randomized, Placebo-and Active-Controlled Efficacy and Safety Study of Bazedoxifene/Conjugated Estrogens Combinations for Treatment of Moderate to Severe Vulvar/Vaginal Atrophy in Postmenopausal Women